These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2907519

  • 1. Serotonergic blockade compared with beta-adrenergic blockade in systemic hypertension: a double-blind comparison of ketanserin with propranolol.
    Okin S, Huberfeld SI, Frishman WH, Soberman J, Laifer L, Greenberg S, Lapsker J, Charlap S, Strom JA.
    J Clin Pharmacol; 1988 Nov; 28(11):1008-16. PubMed ID: 2907519
    [Abstract] [Full Text] [Related]

  • 2. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
    Novo S, Alaimo G, Giordano U, Raineri A, Strano A.
    J Cardiovasc Pharmacol; 1987 Nov; 10 Suppl 3():S104-6. PubMed ID: 2446055
    [Abstract] [Full Text] [Related]

  • 3. The effect of ketanserin on blood pressure and biochemical parameters in treated patients with essential hypertension.
    Wing LM, Chalmers JP, West MJ, Bune AJ, Ayres B, Graham JR.
    Clin Exp Hypertens A; 1984 Nov; 6(6):1107-17. PubMed ID: 6146414
    [Abstract] [Full Text] [Related]

  • 4. Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonist.
    Cameron HA, Waller PC, Ramsay LE.
    Br J Clin Pharmacol; 1987 Dec; 24(6):705-11. PubMed ID: 2894215
    [Abstract] [Full Text] [Related]

  • 5. Serotonin antagonism reduces the adverse symptoms of beta blockade.
    Korlipara K, Gould SE, Taylor NA, Chandler A.
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():127-31. PubMed ID: 1981022
    [Abstract] [Full Text] [Related]

  • 6. Moderate essential hypertension control: a double-blind crossover study between a serotonin antagonist and a post-synaptic alpha-blocker.
    Rosenthal J, Koehle W, Gruebel B, Fisher R.
    J Hypertens Suppl; 1986 Apr; 4(1):S85-7. PubMed ID: 2871145
    [Abstract] [Full Text] [Related]

  • 7. Ketanserin in the treatment of essential hypertension. A double-blind study against metoprolol and a further long-term open treatment.
    Milei J, Lemus J, Bernardiner E.
    Acta Cardiol; 1986 Apr; 41(6):427-41. PubMed ID: 3544622
    [Abstract] [Full Text] [Related]

  • 8. A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.
    Schoenberger JA, Wallin JD, Gorwit JI, Davidov ME, Michelson EL, Poland MP, Frishman WH.
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):840-6. PubMed ID: 2686711
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive properties of ketanserin in combination with beta-adrenergic blocking agents.
    Hedner T, Persson B.
    J Cardiovasc Pharmacol; 1985 Nov; 7 Suppl 7():S161-3. PubMed ID: 2412042
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the efficacy and acceptability of nicardipine and propranolol, alone and in combination, in mild to moderate hypertension.
    Maclean D, Mitchell ET, Laing EM, Macdonald FC, Gough KJ, Dow RJ, McDevitt DG.
    Br J Clin Pharmacol; 1989 May; 27(5):569-80. PubMed ID: 2667597
    [Abstract] [Full Text] [Related]

  • 11. Double-blind comparison of ketanserin and propranolol in hypertensive patients.
    Staessen J, Fagard R, Lijnen P, Rorive G, Amery A.
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):718-25. PubMed ID: 2467091
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

  • 13. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

  • 14. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH, Klein NA, Klein P, Strom JA, Tawil R, Strair R, Wong B, Roth S, LeJemtel TH, Pollack S, Sonnenblick EH.
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [Abstract] [Full Text] [Related]

  • 15. Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol.
    Davidov M.
    Am Heart J; 1985 May; 109(5 Pt 2):1158-67. PubMed ID: 2859780
    [Abstract] [Full Text] [Related]

  • 16. [A cross-over study of ketanserin compared to placebo, beta-adrenergic blockader, diuretic and alpha 1-adrenergic blockader. Cooperative research in the USSR (the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension). Working Group (4)].
    Metelitsa VI, Filatova NP.
    Ter Arkh; 1991 May; 63(9):91-6. PubMed ID: 1684678
    [Abstract] [Full Text] [Related]

  • 17. Effect of ketanserin on blood pressure and biochemical parameters in patients with essential hypertension.
    Wing LM, Chalmers JP, West MJ, Bune AJ, Ayres B, Graham JR.
    J Cardiovasc Pharmacol; 1985 May; 7 Suppl 7():S164-7. PubMed ID: 2412043
    [Abstract] [Full Text] [Related]

  • 18. Hypertension, exercise, and beta-adrenergic blockade.
    Ades PA, Gunther PG, Meacham CP, Handy MA, LeWinter MM.
    Ann Intern Med; 1988 Oct 15; 109(8):629-34. PubMed ID: 2901818
    [Abstract] [Full Text] [Related]

  • 19. Comparative double-blind study of ketanserin versus propranolol in the treatment of essential hypertension.
    Ito K, Omae T, Ikeda M, Iimura O, Yoshinaga K, Ishii M, Kaneko Y, Mizuno Y, Masuyama Y, Takeda T.
    Drugs; 1988 Oct 15; 36 Suppl 1():18-24. PubMed ID: 3071459
    [Abstract] [Full Text] [Related]

  • 20. Controlled trial of ketanserin in hypertension.
    McGourty JC, Silas JH, Cowen KJ.
    Br J Clin Pharmacol; 1985 Jul 15; 20(1):37-40. PubMed ID: 3161531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.